Virus News and Research

Latest Virus News and Research

Does Delta increase the risk of hospitalization compared with Alpha?

A team of researchers conducted a cohort study to understand the risk of hospitalization in patients with either the Delta or Alpha variants of SARS-CoV-2.

12 Sep 2021

Microscopy paired with AI leads to a fast, accurate, and cost-effective COVID-19 test

Beckman researchers paired microscopy with artificial intelligence to develop a COVID-19 test that's fast, accurate, and cost-effective. All we need to do is say "ahh."

12 Sep 2021

Drugs that mimic effects of cigarette smoke could become a potential tool to fight COVID-19

Researchers have identified two drugs that mimic the effect of chemicals in cigarette smoke to bind to a receptor in mammalian cells that inhibits production of ACE2 proteins, a process that appears to reduce the ability of the SARS-CoV-2 virus to enter the cell.

12 Sep 2021

UGA research offers hope for a viable therapeutic to combat COVID-19

As COVID-19 cases continue to skyrocket across the U.S. and the world, few options are available for treating patients infected with the SARS-CoV-2.

11 Sep 2021

Brown researchers receive $4.9 million to study COVID-19 vaccine effectiveness in older adults

To address the pressing issue of diminishing immunity among older adults to COVID-19 as well to vaccines designed to protect against the virus, a $4.9 million award from the U.S. Centers for Disease Control and Prevention will fund a two-year project led by Brown University researchers and conducted by a team spanning multiple institutions.

10 Sep 2021

Convalescent plasma does not reduce risk of intubation or death for COVID-19 hospitalized patients

A major study has found that convalescent plasma does not reduce the risk of intubation or death for COVID-19 patients.

10 Sep 2021

Study identifies FDA-approved drugs that are effective in suppressing SARS-CoV-2 replication

Despite the development of SARS-CoV-2 vaccines, effective therapeutics are needed until worldwide immunity has been achieved.

10 Sep 2021

Genomic surveillance of SARS-CoV-2 reveals how the pandemic was caused in Africa

A genomic surveillance analysis of SARS-CoV-2 in Africa in the first year of the pandemic reveals that the first phase of the pandemic there was caused by importations from outside Africa, and involved limited virus spread, while the second, more deadly phase was fueled by ongoing transmission within the continent and led to emergence of many variants of concern.

10 Sep 2021

Nanoparticles-assisted delivery of antiviral-siRNA for treatment of COVID-19

A review aimed to determine the potential of siRNA as a potential COVID-19 treatment by reviewing the currently available literature.

10 Sep 2021

Breastfeeding women and their babies: the outcomes after mRNA COVID-19 vaccination

Scientists evaluated the effect of vaccination in breastfeeding women and its possible effects in infants in a study involving 180 fully vaccinated, breastfeeding women.

10 Sep 2021

Virus-like nanoparticle vaccine effective against SARS-CoV-2 in animal model

A COVID-19 vaccine, created from a virus-like nanoparticle that displays SARS-CoV-2 spike protein RBDs, effectively protects animal model from infection.

10 Sep 2021

New gene-delivering workhorse could make gene therapy safer, more effective for muscle diseases

Genetic muscle diseases lead to progressive muscle wasting and often early death, with few treatment options and no cure.

9 Sep 2021

Cellular program could turn T cells into effective cancer killers

Cancer-fighting immune cells in patients with lung cancer whose tumors do not respond to immunotherapies appear to be running on a different "program" that makes them less effective than immune cells in patients whose cancers respond to these immune treatments, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center Bloomberg~Kimmel Institute for Cancer Immunotherapy.

9 Sep 2021

Novel combination therapy may prolong viral suppression in patients with HIV

A novel combination treatment may increase the ability of monoclonal antibodies to control viral infection in patients diagnosed with HIV, according to a Northwestern Medicine study published in Science Translational Medicine.

9 Sep 2021

Report highlights the health effects of COVID-19 on Australians during 2020 and early 2021

A new report into the health effects of COVID-19 on Australians during 2020 and early 2021 includes analyses of the years of healthy life lost, international comparisons and impacts on population groups, mental health and the health system.

9 Sep 2021

Are bat retroviruses a threat to humans?

Zoonotic viruses that bats transmit are capable of infecting humans and have caused devastating infections throughout the world.

9 Sep 2021

Healthy plant-based foods may lower COVID-19 risk and severity

Although metabolic conditions such as obesity and type 2 diabetes have been linked to an increased risk of COVID-19, as well as an increased risk of experiencing serious symptoms once infected, the impact of diet on these risks is unknown.

9 Sep 2021

Understanding the changing coronavirus landscape

With the emergence of new SARS-CoV-2 variants such as beta and delta, people are not only getting a refresher course on the Greek alphabet but also experiencing confusion and anxiety about what the variants mean for public health.

9 Sep 2021

Research probes interaction between SARS-CoV-2 and influenza

Researchers from Germany and France tried to determine if epidemiological studies based on co-detection prevalence data can offer a reliable estimation of interactions among respiratory viruses. They designed a simulation study by building on a general epidemiological model of co-circulation of 2 respiratory viruses that cause seasonal epidemics.

8 Sep 2021

Mu SARS-CoV-2 variant highly resistant to neutralization by convalescent and vaccinated sera

Researchers in Japan have warned that the Mu (B.1.621) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – appears to be highly resistant to neutralization by sera from convalescent or vaccinated individuals.

8 Sep 2021

Virus News and Research

Latest Virus News and Research

Does Delta increase the risk of hospitalization compared with Alpha?

Microscopy paired with AI leads to a fast, accurate, and cost-effective COVID-19 test

Drugs that mimic effects of cigarette smoke could become a potential tool to fight COVID-19

UGA research offers hope for a viable therapeutic to combat COVID-19

Brown researchers receive $4.9 million to study COVID-19 vaccine effectiveness in older adults

Convalescent plasma does not reduce risk of intubation or death for COVID-19 hospitalized patients

Study identifies FDA-approved drugs that are effective in suppressing SARS-CoV-2 replication

Genomic surveillance of SARS-CoV-2 reveals how the pandemic was caused in Africa

Nanoparticles-assisted delivery of antiviral-siRNA for treatment of COVID-19

Breastfeeding women and their babies: the outcomes after mRNA COVID-19 vaccination

Virus-like nanoparticle vaccine effective against SARS-CoV-2 in animal model

New gene-delivering workhorse could make gene therapy safer, more effective for muscle diseases

Cellular program could turn T cells into effective cancer killers

Novel combination therapy may prolong viral suppression in patients with HIV

Report highlights the health effects of COVID-19 on Australians during 2020 and early 2021

Are bat retroviruses a threat to humans?

Healthy plant-based foods may lower COVID-19 risk and severity

Understanding the changing coronavirus landscape

Research probes interaction between SARS-CoV-2 and influenza

Mu SARS-CoV-2 variant highly resistant to neutralization by convalescent and vaccinated sera

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Virus News and Research

Latest Virus News and Research

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in